FIELD: medicine, immunology.
SUBSTANCE: vaccine Rudivax is administered to group of girls not younger than 13 years old leaving Thule regions not later than 55 days before departure. Similarly group of homing girls not younger than 13 years old are vaccinated not early than 90 days after coming in Thule regions from other climatic regions.
EFFECT: presence of protective titers of anti-rubella antibodies in vaccinated girls for 1 year after vaccination.
6 ex
Authors
Dates
2006-03-20—Published
2004-07-12—Filed